Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (471-480 of 609) with videos related to

Pageof 61
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2023
Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant PatientsPhilip R Selby, Aaron J Heffernan, David Yeung, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2025
Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapyKatharina M Götz, Sascha Kreuer, Anke-Katrin Volz, et al.
International Journal of Antimicrobial Agents|March 21, 2022
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patientsSebastian G Wicha, Andrea Mair, Ute Chiriac, et al.
International Journal of Antimicrobial Agents|April 11, 2015
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrationsClaire Roger, Bastian Nucci, Nicolas Molinari, et al.
International Journal of Antimicrobial Agents|March 13, 2018
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapyCaleb J P Economou, Jan T Kielstein, David Czock, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
International Journal of Antimicrobial Agents|February 9, 2025
Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patientsNilesh Kumta, Aaron J Heffernan, Xin Liu, et al.
Open Forum Infectious Diseases|December 22, 2021
Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer StudyTimothy M Rawson, Richard C Wilson, Luke S P Moore, et al.
Pageof 61

Showing results (471-480 of 609) with videos related to

Sort By:
Pageof 61
The Journal of Antimicrobial Chemotherapy|June 1, 2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationJason A Roberts, Andrew A Udy, Juergen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2023
Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant PatientsPhilip R Selby, Aaron J Heffernan, David Yeung, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2024
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylateMaría Patricia Hernández-Mitre, Susan C Morpeth, Balasubramanian Venkatesh, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2025
Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapyKatharina M Götz, Sascha Kreuer, Anke-Katrin Volz, et al.
International Journal of Antimicrobial Agents|March 21, 2022
Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patientsSebastian G Wicha, Andrea Mair, Ute Chiriac, et al.
International Journal of Antimicrobial Agents|April 11, 2015
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrationsClaire Roger, Bastian Nucci, Nicolas Molinari, et al.
International Journal of Antimicrobial Agents|March 13, 2018
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapyCaleb J P Economou, Jan T Kielstein, David Czock, et al.
Antimicrobial Agents and Chemotherapy|August 24, 2011
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgeryAlexandra Douglas, Andrew A Udy, Steven C Wallis, et al.
International Journal of Antimicrobial Agents|February 9, 2025
Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patientsNilesh Kumta, Aaron J Heffernan, Xin Liu, et al.
Open Forum Infectious Diseases|December 22, 2021
Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer StudyTimothy M Rawson, Richard C Wilson, Luke S P Moore, et al.
Pageof 61